½ÃÀ庸°í¼­
»óǰÄÚµå
1284228

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå ¿¹Ãø(-2028³â) - À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªº° ¼¼°è ºÐ¼®

Patient Temperature Monitoring Market Forecasts to 2028 - Global Analysis By Type, Type, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°è ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀåÀº 2022³â 36¾ï ´Þ·¯, 2028³â 58¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 8.2%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µÀº ȯÀÚÀÇ Ã¼¿ÂÀ» Á¤±âÀûÀ¸·Î ¶Ç´Â Áö¼ÓÀûÀ¸·Î ÃøÁ¤ÇÏ¿© ȯÀÚÀÇ °Ç°­ »óŸ¦ È®ÀÎÇϰí Ç¥Áذª¿¡¼­ ¹þ¾î³­ º¯µ¿À» ¹ß°ßÇÕ´Ï´Ù. ÀÌ´Â º´¿ø, Áø·á¼Ò, ¿ä¾ç¿ø µî ÀÓ»ó ÇöÀå¿¡¼­ Áúº´ÀÇ ÁøÇàÀ̳ª ¼ö¼ú ÈÄ È¸º¹À» ¸ð´ÏÅ͸µÇÏ°í ¹ß¿­À̳ª °¨¿°À» °¨ÁöÇϱâ À§ÇØ ÀÚÁÖ ¼öÇàµË´Ï´Ù. ü¿ÂÀ» Æò°¡ÇÏ´Â ¹æ¹ý¿¡´Â ±¸°­, ±Í, À̸¶, ±×¸®°í ÃÖ±Ù¿¡´Â ¿þ¾î·¯ºí ±â¼ú µî ´Ù¾çÇÑ ¹æ¹ýÀÌ ÀÖ½À´Ï´Ù.

Åë°è¿¡ µû¸£¸é, ¿µ±¹¿¡¼­´Â ÇâÈÄ 10³â°£ ¾à 500¸¸ ¸íÀÌ ¸¸¼ºÁúȯÀ¸·Î ÀÎÇØ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿µ±¹¿¡¼­´Â ÀÌ¹Ì 1,500¸¸ ¸í ÀÌ»óÀÌ Àû¾îµµ ÇÑ °¡Áö ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, ÀÌ ¼öÄ¡´Â ´õ ´Ã¾î³¯ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÃËÁø¿äÀÎ

°¨¿°º´ÀÇ È®»ê

ÇöÀç ¼¼°è Àα¸´Â ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áö¿ªÀÇ Àα¸ ¹Ðµµ°¡ ³ô¾ÆÁö¸é Àα¸°¡ Áõ°¡ÇÏ¿© Àü¿°º´°ú ¹ÙÀÌ·¯½º °¨¿°À» ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ÀÇ À§ÇèÀÌ °¡Àå ³ôÀº °ÍÀº ³ëÀΰú ¾î¸°ÀÌÀÔ´Ï´Ù. ü¿Â º¯È­´Â ÀϺΠ¹ÙÀÌ·¯½º¼º ÁúȯÀÇ ÀüÇüÀûÀÎ Áõ»óÀÔ´Ï´Ù. µû¶ó¼­ ü¿ÂÀ» ½Å¼ÓÇÏ°Ô ¸ð´ÏÅ͸µÇÏ¸é ´Ù¾çÇÑ Áúº´À» È¿°úÀûÀ¸·Î Áø´ÜÇϰí Ä¡·áÇÒ ¼ö Àֱ⠶§¹®¿¡ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¾ïÁ¦¿äÀÎ

³·Àº ÀÎÁöµµ

º¸±ÞÀ» °¡·Î¸·´Â ÁÖ¿ä ¾î·Á¿òÀº ÀÇ»ç ¹× ±âŸ ÀÇ·á Àü¹®°¡°¡ Á¦Á¶¾÷üÀÇ °³¼± »çÇ׿¡ ´ëÇØ ¾ËÁö ¸øÇÑ´Ù´Â Á¡°ú ÀÌ·¯ÇÑ ±â±â¸¦ Á¶ÀÛÇϰí ó¸®ÇÏ´Â µ¥ ÇÊ¿äÇÑ ±³À° ¹× °æÇèÀ» °¡Áø Á÷¿øÀÌ ºÎÁ·ÇÏ´Ù´Â Á¡ÀÔ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí Á÷Àå ¿Âµµ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¿ì·Á´Â ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

±âȸ:

ÅëÇÕ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»ó

½º¸¶Æ®Æù°ú ¿¬°áµÈ ³×Æ®¿öÅ©¿Í °°Àº ÅëÇÕ ¸ð´ÏÅ͸µ ±â¼úÀÇ °¡¿ë¼ºÀÌ ³ô¾ÆÁö´Â °ÍÀº ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, ÈÞ´ë¿ë ½ÉÀå ¿ø°Ý ÃøÁ¤ ÀåÄ¡, ÈÞ´ë¿ë PDA ½Ã½ºÅÛ, º´¿ø ¿Ü·¡ ȯÀÚ À̺¥Æ® ¸ð´ÏÅÍ µîÀÌ °³¹ßµÆ½À´Ï´Ù. ¾÷°è¿¡¼­ ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ¿ë Á¦Ç°µéÀÌ ¼Ó¼Ó Ãâ½ÃµÇ°í ÀÖ¾î ½ÃÀå È®´ë°¡ ¿¹»óµË´Ï´Ù.

À§Çù

ü¿Â ¸ð´ÏÅ͸µ ÀåºñÀÇ °íºñ¿ë

½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ¿äÀÎÀ¸·Î´Â Ư¼ö ¿Âµµ ¸ð´ÏÅ͸µ ÀåºñÀÇ ³ôÀº ºñ¿ë°ú ÀÌ·¯ÇÑ Àåºñ¸¦ È¿À²ÀûÀ¸·Î ´Ù·ç°í °ü¸®ÇÒ ¼ö ÀÖ´Â °æÇèÀÚ°¡ ºÎÁ·ÇÏ´Ù´Â Á¡À» µé ¼ö ÀÖ½À´Ï´Ù. ¼öÀºÀ» »ç¿ëÇϴ ü¿Â°è·Î ÀÎÇÑ ¼öÀº Áßµ¶ÀÇ À§ÇèÀº ½ÃÀå È®´ë¸¦ ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ü¿Â°è ³»ºÎÀÇ Àº±¸´Â À¯¸®°¡ ±úÁö°Å³ª Á¦´ë·Î ¼¼Ã´µÇÁö ¾ÊÀ¸¸é ÀÎü¿¡ ¸Å¿ì À§ÇèÇÕ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19°¡ °æÁ¦¿¡ ¹ÌÄ¡´Â ÁÖ¿ä ¿µÇâÀº ÀǾàǰ ¹× ¹é½Å »ý»ê ¹× ¼ö¿ä¿¡ ´ëÇÑ Á÷Á¢ÀûÀÎ ¿µÇâ, À¯Åë ½Ã½ºÅÛÀÇ È¥¶õ, ±â¾÷ ¹× ±ÝÀ¶ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ µî ¼¼ °¡Áö°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ȯÀÚ ¿Âµµ ¹× ½Àµµ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¦Ç° Ãâ½Ã Áõ°¡·Î ÀÎÇØ COVID-19 »çÅ´ ȯÀÚ ¿Âµµ ¹× ½Àµµ ¸ð´ÏÅ͸µ ¼¼°è ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ Àåºñ´Â ȯÀÚ°¡ ¸¸¼º ÁúȯÀ» Àß °ü¸®Çϰí ȯÀÚ¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡´Â ±Ùº»ÀûÀÎ º´¸®¸¦ ÀÌÇØÇÏ´Â µ¥ ÇÊ¿äÇÑ ¸®¼Ò½º¸¦ Á¦°øÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿þ¾î·¯ºí ¿¬¼Ó ¸ð´ÏÅ͸µ ¼¾¼­ ºÐ¾ß°¡ ÃÖ´ë ±Ô¸ðÀÏ °ÍÀ¸·Î ¿¹»ó

¿þ¾î·¯ºí ¿¬¼Ó ¸ð´ÏÅ͸µ ¼¾¼­ ºÐ¾ß´Â ¿þ¾î·¯ºí ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀÌ ºü¸£°Ô Áõ°¡ÇÔ¿¡ µû¶ó À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹«¼± µ¥ÀÌÅÍ Àü¼Û ±â¼úÀÌ °³¼±µÇ°í Á¢±Ù¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿ø°Ý ÀÇ·á ¹× È¯ÀÚ ¸ð´ÏÅ͸µ °³¼±À» À§ÇÑ ½Ã½ºÅÛ ±¸ÃàÀÌ ´õ¿í °£´ÜÇØÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÀüµµ, Ç÷´ç, Ç÷¾Ð°ú °°Àº Áß¿äÇÑ ÁöÇ¥´Â ¿þ¾î·¯ºí ¹ÙÀÌ¿À¼¾¼­·Î ÃøÁ¤µÇ¾î ¸ð¹ÙÀÏ ¹«¼± ³×Æ®¿öÅ©¸¦ ÅëÇØ Áß¾Ó ÄÄÇ»ÅÍ·Î Áß°èµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ºñħ½ÀÀû ¿Âµµ ¸ð´ÏÅ͸µ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»ó

ºñħ½ÀÀû ü¿Â ¸ð´ÏÅ͸µ ºÐ¾ß´Â ´õ Æí¾ÈÇϰí, Á¢±ÙÇϱ⠽±°í, Á¤È®Çϰí, °£´ÜÇÑ Ã¼¿Â ¸ð´ÏÅ͸µ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¸°­ ³» ¿Âµµ ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±¸°­ ³» ¿Âµµ°èÀÇ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃøµÎ µ¿¸Æ ¹× º¸Á¶ ¿Âµµ ¸ð´ÏÅ͸µÀÇ ÀåÁ¡ÀÎ ºü¸¥ ÃøÁ¤, »ç¿ë ÆíÀǼº ¹× ÃÖ¼Ò Ä§½ÀÀ¸·Î ÀÎÇØ ÀÌ ¹üÁÖÀÇ È¯ÀÚ ¿Âµµ ¸ð´ÏÅ͸µ ½ÃÀå ¼öÀÍÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¾Æ½Ã¾ÆÅÂÆò¾çÀº Äڷγª ¹ÙÀÌ·¯½º ´ëÀ¯Çà ±â°£ µ¿¾È ¿Âµµ °ü¸®ÀÇ Çʿ伺¿¡ ´ëÇÑ »çȸÀû ÀνÄÀÌ ³ô¾ÆÁö°í ½ÃÀåÀÇ ¹ÌÃæÁ· ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇÑ ±â¾÷ÀÇ Ä§Åõ·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀåÀº ´ç´¢º´°ú ¾ÏÀ» Æ÷ÇÔÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ȯÀÚ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ È°¹ßÇÑ ¿¬±¸·Î ÀÎÇØ Å©°Ô »ó½ÂÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, ½ÅÈï °æÁ¦ ±¹°¡, ³ôÀº ±¹¹Î °¡Ã³ºÐ ¼Òµæ, ÀÇ·á ÁöÃâ Áõ°¡, ¼ö¼ú °Ç¼ö Áõ°¡, ¼öÇ÷ ¹× ÇåÇ÷ Áõ°¡ µîÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ½Ã½ºÅÛ¿¡¼­´Â ȯÀÚÀÇ °Ç°­ Æò°¡¿¡ À¯¸®Çϱ⠶§¹®¿¡ ¸·´ëÇÑ ÁöÃâ, ½ÅÁ¦Ç° µµÀÔ, ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ·¯½º °¨¿°ÀÇ ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå »ó½ÂÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ¹ßÀü:

2022³â 4¿ù, Àû¿Ü¼± ½ºÄ³³Ê, ¿Âµµ°è, ¼¾¼­ Á¦Á¶¾÷üÀÎ Exergen CorporationÀº ¹Ì±¹ ½ÄǰÀǾ౹(FDA)¿¡ ºÎÁ¤È®ÇÑ ºñÁ¢ÃË½Ä Àû¿Ü¼± ü¿Â°è°¡ °øÁß º¸°Ç¿¡ À§ÇèÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ´Ù¸ç ȸ¼ö ¹× ÇâÈÄ ÆÇ¸Å ±ÝÁö¸¦ ¿äûÇß½À´Ï´Ù.

2021³â 2¿ù, ij³í ¼Ö·ç¼ÇÁî ¾Æ¸Þ¸®Ä«(¹Ì±¹)´Â FDA ÀÎÁõÀ» ¹ÞÀº ÀÚµ¿È­µÈ µðÁöÅÐ ³ëÅÍÄ¡ ÀÓ»ó ü¿Â°è 'welloStationXTM'¸¦ Ãâ½ÃÇß½À´Ï´Ù.

2020³â 10¿ù, ¸¶½Ã¸ð´Â ¼öµ¿À¸·Î ü¿ÂÀ» ÃøÁ¤ÇÏ´Â ´ë½Å ȯÀÚÀÇ Ã¼¿ÂÀ» ¿¬¼ÓÀûÀ¸·Î ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ¸µÅ©Çü ¼¾¼­ ½Ã½ºÅÛ 'Radius T Continuous Thermometer for consumers'¸¦ Ãâ½ÃÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

º» º¸°í¼­°¡ Á¦°øÇÏ´Â °Íµé

  • Áö¿ª ¹× ±¹°¡º° ½ÃÀåÁ¡À¯À² Æò°¡
  • ½Å±Ô ÁøÀÔ±â¾÷¿¡ ´ëÇÑ Àü·«Àû Á¦¾ð
  • 2020³â, 2021³â, 2022³â, 2025³â, 2028³â ½ÃÀå µ¥ÀÌÅ͸¦ Æ÷ÇÔ
  • ½ÃÀå µ¿Çâ(ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, À§Çù, °úÁ¦, ÅõÀÚ ±âȸ, ±ÇÀå »çÇ×)
  • ½ÃÀå ÃßÁ¤¿¡ ±â¹ÝÇÑ ÁÖ¿ä »ç¾÷ ºÎ¹®ÀÇ Àü·«Àû Á¦¾È
  • ÁÖ¿ä °øÅë Æ®·»µå¸¦ ¸ÅÇÎÇÑ °æÀï »óȲ.
  • »ó¼¼ÇÑ Àü·«, À繫 ¹× ÃÖ±Ù °³¹ß ÇöȲÀ» Æ÷ÇÔÇÑ È¸»ç ÇÁ·ÎÇÊ
  • Ãֽбâ¼ú ¹ßÀüÀ» ¸ÅÇÎÇÏ´Â °ø±Þ¸Á µ¿Çâ

¹«·á ¸ÂÃãÇü ¼­ºñ½º Á¦°ø:

ÀÌ º¸°í¼­¸¦ ±¸¸ÅÇÑ °í°´¿¡°Ô´Â ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ Á¦°øÇÕ´Ï´Ù.

  • ȸ»ç ÇÁ·ÎÇÊ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ªº° ¼¼ºÐÈ­
    • °í°´ÀÇ ¿äû¿¡ µû¶ó ÁÖ¿ä ±¹°¡ÀÇ ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¿ªÀû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : Á¦Ç°º°

  • ½º¸¶Æ® ¿Âµµ °¨½Ã ÆÐÄ¡
  • ¿þ¾î·¯ºí ¿¬¼Ó °¨½Ã ¼¾¼­
  • ÇÚµåÇïµå ¿Âµµ °¨½Ã Àåºñ
    • Àû¿Ü¼± ¿Âµµ°è
    • µðÁöÅÐ ¿Âµµ°è
    • ¼öÀº ü¿Â°è
  • Ź»ó ¿Âµµ °¨½Ã Àåºñ
    • ½ÉºÎ ü¿ÂÀ» Áö¼ÓÀûÀ¸·Î °¨½ÃÇÏ´Â Àåºñ
    • ºñħ½ÀÀûÀÎ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º
  • ħ½ÀÀû ¿Âµµ °¨½Ã Àåºñ
  • ±âŸ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : À¯Çüº°

  • ħ½ÀÀû ¿Âµµ ¸ð´ÏÅ͸µ
    • ºñÀεΠ¿Âµµ ¸ð´ÏÅ͸µ
    • Á÷Àå¿Â¸ð´ÏÅ͸µ
    • ¹æ±¤ ¿Âµµ ¸ð´ÏÅ͸µ
    • ½Äµµ ¿Âµµ ¸ð´ÏÅ͸µ
  • ºñħ½ÀÀû ¿Âµµ ¸ð´ÏÅ͸µ
    • °í¸· ¿Âµµ ¸ð´ÏÅ͸µ
    • ±¸°­ ¿Âµµ ¸ð´ÏÅ͸µ
    • °Üµå¶ûÀÌ µ¿¸Æ ¹× ÃøµÎ µ¿¸Æ ¿Âµµ ¸ð´ÏÅ͸µ
  • ±âŸ À¯Çü

Á¦7Àå ¼¼°èÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ¿ëµµº°

  • ¼öÇ÷
  • Àúü¿ÂÁõ
  • ¸¶Ãë
  • ¹ß¿­¡¤¹ß¿­
  • ±âŸ ¿ëµµ

Á¦8Àå ¼¼°èÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °£º´½Ã¼³
  • º´¿ø
  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • ȨÄÉ¾î ¼³Á¤
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • Koninklijke Philips N.V.
  • Hill-Rom Holdings, Inc.
  • Becton, Dickinson and Company
  • Omega Engineering
  • Paul Hartmann AG
  • Braun GmbH
  • Briggs Healthcare
  • Terumo Corporation
  • iHealth
  • Dragerwerk
  • Microlife
  • Omron Healthcare Inc.
  • Cardinal Health Inc.
  • 3M
  • Masimo Corporation
  • Beurer GmbH
ksm 23.06.09

According to Stratistics MRC, the Global Patient Temperature Monitoring Market is accounted for $3.6 billion in 2022 and is expected to reach $5.8 billion by 2028 growing at a CAGR of 8.2% during the forecast period. Patient temperature monitoring involves regularly or continuously taking a person's temperature to check on their wellbeing and spot any variations from the norm. This is frequently done in clinical settings such as hospitals, clinics, or long-term care facilities to monitor the progression of diseases, recovery from surgery, or to detect fever or infection. There are many ways to assess the temperature, including oral, ear, forehead, and more recently, wearable technologies.

According to statistics, about 5 million individuals would die in the U.K. during the next ten years as a result of chronic diseases. More than 15 million people in the U.K. already have at least one chronic disease, and this figure is predicted to climb further.

Market Dynamics:

Driver:

Rising prevalence of infectious diseases

Currently, the global population is expanding quickly. Increased human density in a region is associated with population growth, which promotes the transmission of infectious illnesses and viruses. The people most at risk for such diseases are the elderly and children. Changes in body temperature are typical symptoms of several viral illnesses. As a result, prompt temperature monitoring can lead to effective diagnosis and treatment of various disorders, which is fueling the market's expansion.

Restraint:

Lack of awareness

The main difficulties preventing their widespread use are a lack of knowledge among physicians and other healthcare professionals about improvements made by manufacturers and a shortage of employees with the necessary training and experience to operate and process these devices. The market is being restrained in its growth, nevertheless, by worries over rectal temperature monitoring.

Opportunity:

Enhanced accessibility to integrated monitoring technology

The rising availability of integrated monitoring technology, such as smartphones and connected networks, is a significant factor that is encouraging growth. Remote monitoring systems, portable cardiac telemetry devices, portable PDA systems, and hospital outpatient event monitors have all been developed as a result. The market is expected to grow as more products for patient temperature monitoring are released by industry players.

Threat:

High cost of temperature monitoring equipment

The challenges limiting market growth are the high cost of specialised temperature monitoring equipment and a lack of experienced people who can handle and manage these devices efficiently. The risk of mercury poisoning from mercury-based thermometers is impeding market expansion. The silver ball inside the thermometer is extremely dangerous to humans if the glass breaks or is not cleaned properly.

COVID-19 Impact:

Three primary manners in which COVID-19 has impacted the economy are through its direct impact on the manufacture and demand of pharmaceuticals and vaccines, the disruption of distribution systems, and its financial impact on businesses and financial markets. Due to increased demand for patient temperature monitoring equipment and a rise in product introductions, the COVID-19 pandemic did, however, have a positive effect on the global market for patient temperature monitoring. Devices for remote patient monitoring give patients the resources they need to successfully manage their chronic illnesses and understand the underlying pathologies that affect them specifically.

The wearable continuous monitoring sensors segment is expected to be the largest during the forecast period

The wearable continuous monitoring sensors segment is estimated to have a lucrative growth, due to the rapidly rising regulatory approvals for wearable monitoring devices. As wireless data transmission technology improve and become more accessible, it will become simpler to create systems for telehealth and improved patient monitoring. Vital indications like electrocardiography, blood sugar levels, and blood pressure are measured using wearable biosensors and relayed to a central computer via mobile wireless networks.

The non-invasive temperature monitoring segment is expected to have the highest CAGR during the forecast period

The non-invasive temperature monitoring segment is anticipated to witness the fastest CAGR growth during the forecast period, due to factors like more pleasant, accessible, accurate, and simple temperature monitoring. Oral thermometer demand is also rising as a result of the increased requirement for monitoring oral temperature. Additionally, the benefits of temporal artery and auxiliary temperature monitoring, such as quick measurement, ease of use, and minimal intrusion, are fueling this category's patient temperature monitoring market revenue.

Region with Largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising public awareness of the need of temperature control during the corona virus pandemic and the penetration of businesses to meet the market's unmet demands. The region's market is expected to rise significantly as a result of the rising prevalence of chronic diseases including diabetes and cancer as well as active research into patient monitoring technology.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the presence of major market players, a developed economy, high disposable income of people, increased healthcare spending, a large volume of surgeries, and an increase in blood transfusion and donation. The healthcare system is seeing tremendous expenditures, the introduction of new products, and a growth in the use of patient temperature monitoring devices as a result of the advantages of patient health evaluation. Furthermore, the market is anticipated to rise faster due to the increasing frequency of viral outbreaks.

Key players in the market:

Some of the key players profiled in the Patient Temperature Monitoring Market include Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Becton, Dickinson and Company, Omega Engineering, Paul Hartmann AG , Braun GmbH, Briggs Healthcare, Terumo Corporation, iHealth, Dragerwerk, Microlife, Omron Healthcare Inc., Cardinal Health Inc., 3M, Masimo Corporation and Beurer GmbH.

Key Developments:

In April 2022, Exergen Corporation, a manufacturer of infrared scanners, thermometer, and sensors calls on U.S. Food and Drug Administration (FDA) to recall and prevent future sales of non-contact infrared thermometers, whose inaccuracy is danger to the public health.

In February 2021, Canon Solutions America Inc. (U.S.) introduced welloStationXTM, an automated, FDA-cleared, digital, and no-touch clinical thermometer.

In October 2020, Masimo announced the release of the Radius T Continuous Thermometer for consumers, a linked sensor system that can continuously take a patient's temperature in place of a manual procedure.

Products Covered:

  • Smart Temperature Monitoring Patches
  • Wearable Continuous Monitoring Sensors
  • Handheld Temperature Monitoring Devices
  • Table-Top Temperature Monitoring Devices
  • Invasive Temperature Monitoring Devices
  • Other Products

Types Covered:

  • Invasive Temperature Monitoring
  • Non-invasive Temperature Monitoring
  • Other Types

Applications Covered:

  • Blood Transfusion
  • Hypothermia
  • Anesthesia
  • Pyrexia/Fever
  • Other Applications

End Users Covered:

  • Nursing Facilities
  • Hospitals
  • Ambulatory Care Centers
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Patient Temperature Monitoring Market, By Product

  • 5.1 Introduction
  • 5.2 Smart Temperature Monitoring Patches
  • 5.3 Wearable Continuous Monitoring Sensors
  • 5.4 Handheld Temperature Monitoring Devices
    • 5.4.1 Infrared Thermometers
    • 5.4.2 Digital Thermometers
    • 5.4.3 Mercury Thermometers
  • 5.5 Table-Top Temperature Monitoring Devices
    • 5.5.1 Continuous core body temperature monitoring devices
    • 5.5.2 Non-invasive vital signs monitoring devices
  • 5.6 Invasive Temperature Monitoring Devices
  • 5.7 Other Products

6 Global Patient Temperature Monitoring Market, By Type

  • 6.1 Introduction
  • 6.2 Invasive Temperature Monitoring
    • 6.2.1 Nasopharynx Temperature Monitoring
    • 6.2.2 Rectal Temperature Monitoring
    • 6.2.3 Urinary Bladder Temperature Monitoring
    • 6.2.4 Esophageal Temperature Monitoring
  • 6.3 Non-invasive Temperature Monitoring
    • 6.3.1 Tympanic Membrane Temperature Monitoring
    • 6.3.2 Oral Temperature Monitoring
    • 6.3.3 Axillary and Temporal Artery Temperature Monitoring
  • 6.4 Other Types

7 Global Patient Temperature Monitoring Market, By Application

  • 7.1 Introduction
  • 7.2 Blood Transfusion
  • 7.3 Hypothermia
  • 7.4 Anesthesia
  • 7.5 Pyrexia/Fever
  • 7.6 Other Applications

8 Global Patient Temperature Monitoring Market, By End User

  • 8.1 Introduction
  • 8.2 Nursing Facilities
  • 8.3 Hospitals
  • 8.4 Ambulatory Care Centers
  • 8.5 Home Care Settings
  • 8.6 Other End Users

9 Global Patient Temperature Monitoring Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Koninklijke Philips N.V.
  • 11.2 Hill-Rom Holdings, Inc.
  • 11.3 Becton, Dickinson and Company
  • 11.4 Omega Engineering
  • 11.5 Paul Hartmann AG
  • 11.6 Braun GmbH
  • 11.7 Briggs Healthcare
  • 11.8 Terumo Corporation
  • 11.9 iHealth
  • 11.10 Dragerwerk
  • 11.11 Microlife
  • 11.12 Omron Healthcare Inc.
  • 11.13 Cardinal Health Inc.
  • 11.14 3M
  • 11.15 Masimo Corporation
  • 11.16 Beurer GmbH
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦